Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients.
Webb MJ, Neth BJ, Webb LM, Van Gompel JJ, Link MJ, Neff BA, Carlson ML, Driscoll CL, Dornhoffer J, Ruff MW, Anderson KA, Kizilbash SH, Campian JL, Uhm JH, Lane JI, Benson JC, Blezek DJ, Mehta PM, Bathla G, Sener UT.
Webb MJ, et al. Among authors: ruff mw.
Neurooncol Adv. 2023 Sep 22;5(1):vdad123. doi: 10.1093/noajnl/vdad123. eCollection 2023 Jan-Dec.
Neurooncol Adv. 2023.
PMID: 37841698
Free PMC article.